Physician profile
Sai Alla
NPI 1396272357
$9,851.52
in general payments reported to CMS, 2019-2025
14 companies · $1,705 in 2025
The $1,705 reported for 2025 was more than what 96% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $48.00 · 2022: $3,833 · 2023: $547 · 2024: $3,719 · 2025: $1,705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,944 · Food and Beverage: $2,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,943.70 |
| Food and Beverage | $2,026.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,754.99 | 2022-2025 | Eterna |
| Si-Bone, INC. | $1,917.04 | 2024 | |
| Boston Scientific Corporation | $1,880.52 | 2022-2025 | Intracept, Superion Indirect Decompression System, General - Pain Management |
| Stryker Corporation | $1,388.39 | 2025 | Optablate, Mild Device Kit, Ivas |
| Nevro Corp. | $359.17 | 2023-2024 | Senza |
| Medtronic, INC. | $218.60 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Collegium Pharmaceutical, INC. | $164.39 | 2022-2023 | Xtampza, Belbuca |
| Forte Bio-Pharma LLC | $32.27 | 2023 | Prolate, Nalocet |
| Globus Medical, INC. | $27.12 | 2025 | Vyrsa V1 |
| Biotronik Nro, INC. | $26.13 | 2025 | Prospera |
| Spr Therapeutics, INC | $22.36 | 2022-2024 | Sprint Pns System |
| Saluda Medical Americas, INC. | $21.21 | 2025 | Evoke |
| Averitas Pharma INC. | $20.97 | 2023 | Qutenza |
| Bioventus LLC | $18.36 | 2024 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sai Alla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.